资讯

LigaChem Biosciences said Tuesday that its U.K. partner, Iksuda Therapeutics, has received U.S. FDA approval to expand its ...
Gilead Sciences just hit Korea’s accelerator with Livdelzi (seladelpar) -- and Ipsen’s rival Iqirvo (elafibranor) may be ...
ST Pharm announced said it has signed two new supply contracts worth a combined $18.25 million (24.9 billion won) with two ...
Ybrain's MINDD STIM, a device-based antidepressant treatment, has received a two-year extension under Korea’s new medical ...
Dong-A ST said it has entered into a co-promotion agreement with Ipsen Korea for Diphereline (ingredient: triptorelin), a ...
Korean researchers have proposed a new treatment strategy for glioblastoma, an incurable brain tumor that does not respond to ...
Samsung Bioepis and Hanmi Pharmaceutical on Tuesday jointly launched Obodense (ingredient: denosumab), a biosimilar ...
Astellas Korea, the Korean affiliate of global life sciences company Astellas Pharma, said it has named former Daiichi Sankyo ...
In April, South Korea became the first country in the world to pass a standalone synthetic-biology law, effectively signing a ...
The structure of hospital care is evolving. With patient safety, quality of care, and sustainable healthcare systems becoming ...
Celltrion Pharm said it has launched Nesina Met Extended-Release (XR) tablets, a fixed-dose combination treatment for type 2 ...
Spark Biopharma, a Korean biotech company specializing in first-in-class drug discovery, said it has signed a joint research ...